ISRAEL 21c
by Ruthie Blum
June 2, 2014
After eight years of painstaking research, Israeli life-sciences company Eventus Diagnostics (EventusDx) has produced a blood test for the early detection of breast cancer.
The Octava Pink test is now available in Israel and Italy, and is undergoing clinical trials to receive US Food and Drug Administration approval.
This is the first blood test ever that can reveal cancer, not merely markers that might indicate cancer or something else. Its innovation also lies in its examination of antibodies in the blood to pinpoint this specific cancer.
Molecular biologist Galit Yahalom — who heads the research team at the EventusDx offices and lab, located in Moshav Ora outside of Jerusalem – explains the breakthrough to ISRAEL21c.
“For the last decade, we have known that there is a connection between cancer and the immune system,” says Yahalom, a 43-year-old mother of two from Modi’in who has been working on this project since its inception.
ArchitectGuy on Israel 